Nerve grafting to preserve erections after prostate removal
Part of Cancer, Kidney & urinary, Mental health clinical trials.
This trial tests if a nerve grafting technique can help preserve erectile function after robotic surgery for high-risk localized prostate cancer. It may be an option for men with good preoperative erectile function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-risk localized prostate cancer (Gleason 8 or higher, PSA 20 or higher, or tumor beyond the prostate on MRI).
- You are scheduled for standard robotic prostate removal.
- You have good erectile function before surgery (score of 17 or higher on a standardized questionnaire).
- You have not had previous pelvic surgery or radiation.
- You have not had prior focal therapy for prostate cancer.
- You are able to complete questionnaires or have someone to help you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new nerve surgery to help men regain erections after prostate cancer surgery. It's for men who have had moderate to severe erectile dysfunction for at least 12 to 18 months after their prostate removal.
This trial compares two nerve-sparing techniques during robotic prostatectomy to see which better preserves urinary and sexual function while still effectively removing the cancer. It is for men with early-stage, favorable-risk prostate cancer who are good surgical candidates.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This study tests whether using a special ultrasound tool during prostate cancer surgery helps protect the nerves that control erections. If you have good erectile function and are scheduled for nerve-sparing prostate removal, this trial may be a good fit for you.
This trial tests whether a medicine called 4-aminopyridine (4AP) can help recover or protect erectile function after “nerve-sparing” prostate surgery. It’s for men with early-stage, non-spread prostate cancer who are scheduled for robotic prostate surgery and have good baseline erections.
This early-stage trial tests a treatment designed to protect nerves during prostate removal surgery for cancer. The goal is to help patients recover sexual function after surgery, which is a common concern.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.